These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27370408)

  • 21. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone health in living kidney donors.
    Naylor KL; Garg AX
    Curr Opin Urol; 2014 Nov; 24(6):624-8. PubMed ID: 25144146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women.
    Hu W; He J; Fu W; Wang C; Yue H; Gu J; Zhang H; Zhang Z
    J Clin Densitom; 2019; 22(2):179-184. PubMed ID: 30228048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation.
    Dolgos S; Hartmann A; Bønsnes S; Isaksen GA; Godang K; Ueland T; Pfeffer P; Bollerslev J
    Scand J Clin Lab Invest; 2009; 69(2):161-7. PubMed ID: 18972258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and early effects of triiodothyronine administration on serum markers of bone and mineral metabolism.
    Kobe N; Takamatsu J; Ito M; Sakane S; Ohsawa N
    Endocrine; 1999 Feb; 10(1):53-6. PubMed ID: 10403571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
    Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ
    PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and long term mineral metabolism adaptation in living kidney donors: a prospective study.
    Ponte B; Trombetti A; Hadaya K; Ernandez T; Fumeaux D; Iselin C; Martin PY; de Seigneux S
    Bone; 2014 May; 62():36-42. PubMed ID: 24495507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E; Hill KM; Jones R; Cacucci BM; Gupta CE; Acton A; Considine RV; Peacock M
    J Clin Endocrinol Metab; 2012 May; 97(5):1655-62. PubMed ID: 22362819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone turnover, calcium homeostasis, and vitamin D status in Danish vegans.
    Hansen TH; Madsen MTB; Jørgensen NR; Cohen AS; Hansen T; Vestergaard H; Pedersen O; Allin KH
    Eur J Clin Nutr; 2018 Jul; 72(7):1046-1054. PubMed ID: 29362456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease.
    Yang ZK; Ying C; Zhao HY; Fang YH; Chen Y; Shen WF
    J Zhejiang Univ Sci B; 2015 May; 16(5):362-9. PubMed ID: 25990053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of carbamazepine on serum parathormone, 25- hydroxyvitamin D, bone specific alkaline phosphatase, C-telopeptide, and osteocalcin levels in healthy rats.
    Kir HM; Garip S; Sahin D; Öztaş B
    Bosn J Basic Med Sci; 2012 Nov; 12(4):240-4. PubMed ID: 23198939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone biomarkers in patients with chronic traumatic spinal cord injury.
    Sabour H; Norouzi Javidan A; Latifi S; Larijani B; Shidfar F; Vafa MR; Heshmat R; Emami Razavi H
    Spine J; 2014 Jul; 14(7):1132-8. PubMed ID: 24139865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone metabolism during interferon-alpha treatment of essential thrombocythemia.
    Kusec R; Kusec V; Gisslinger B; Woloszczuk W; Gisslinger H
    Wien Klin Wochenschr; 2004 Jan; 116(1-2):37-41. PubMed ID: 15030122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy.
    Nettekoven S; Ströhle A; Trunz B; Wolters M; Hoffmann S; Horn R; Steinert M; Brabant G; Lichtinghagen R; Welkoborsky HJ; Tuxhorn I; Hahn A
    Eur J Pediatr; 2008 Dec; 167(12):1369-77. PubMed ID: 18270736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vitamin D supplementation or fortification on bone turnover markers in women: a systematic review and meta-analysis.
    Nasimi N; Jamshidi S; Askari A; Zolfaghari N; Sadeghi E; Nouri M; Bellissimo N; Faghih S
    Br J Nutr; 2024 May; 131(9):1473-1487. PubMed ID: 38221822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.